Delirium, Dementia, Amnestic, Cognitive Disorders  >>  bradanicline (ATA-101)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
bradanicline (ATA-101) / CODA Biotherap
NCT01254448: Multiple Ascending Dose Study of TC-5619 in Healthy Elderly Subjects and Subjects With Alzheimer's Disease

Completed
1
38
US
TC-5619, Placebo
Targacept Inc.
Alzheimer's Disease
03/11
05/11

Download Options